GGrantIndex
Sort

64,565 grants matching drug discovery

PAAR4Kids-Pharmacogenomics of Anticancer Agents Research in Children

$1,563,234
Mary V. Relling · St. Jude Children'S Research Hospital · U01 · FY2012 · GM

Molecular and Cellular Mechanisms of Osteoporosis

$1,563,019
Stavros C. Manolagas · Univ Of Arkansas For Med Scis · P01 · FY2014 · AG

Molecular and Cellular Mechanisms of Osteoporosis

$1,563,019
Stavros C. Manolagas · Univ Of Arkansas For Med Scis · P01 · FY2016 · AG

SNM: Scalable Nanomanufacturing of Fab Compatible High-Density Nanowire Arrays for High-Throughput Drug Screening

$1,562,878
Shadi A Dayeh · University Of California-San Diego · · FY2017 · ENG

Molecular and Cellular Mechanisms of Osteoporosis

$1,562,136
Stavros C. Manolagas · Univ Of Arkansas For Med Scis · P01 · FY2012 · AG

Qualification of Patient-Derived Biomimetic Liver MPS as Drug Discovery Tools for Drug Metabolism, Toxicity, Drug Efficacy Testing and Clinical Trial Cohort Selection

$1,561,914
Mark E Schurdak · University Of Pittsburgh At Pittsburgh · U2C · FY2024 · TR

Gene Therapy for Alzheimer's Disease

$1,561,324
Mark H Tuszynski · University Of California, San Diego · P01 · FY2014 · AG

Boston-Area Research Training Program in Biomedical Informatics

$1,561,223
Lucila Ohno-Machado · Harvard Medical School · T15 · FY2007 · LM

Consortium for Translational Research in Marfan Syndrome

$1,560,010
Francesco B Ramirez · Icahn School Of Medicine At Mount Sinai · P01 · FY2011 · AR

A comprehensive platform for novel therapy development from the microbiome

$1,559,799
Curtis Huttenhower · Broad Institute, Inc. · R24 · FY2019 · DK

Yale/NIDA Neuroproteomics Center

$1,559,655
Kenneth Robert Williams · Yale University · P30 · FY2019 · DA

MEDICINAL CHEMISTRY FACILITY

$1,559,474
Gregg Pioske · University Of Minnesota · N01 · FY2014 · HD

Development Of Theoretical Methods For Studying Biological Macromolecules

$1,559,118
Bernard R Brooks · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL

Gene Therapy for Alzheimer's Disease

$1,558,722
Mark H Tuszynski · University Of California, San Diego · P01 · FY2011 · AG

Cell Type-Specific Proteins that Promote Resilience to Cognitive Aging and Alzheimer's Disease

$1,558,434
Catherine Cook Kaczorowski · University Of Michigan At Ann Arbor · R01 · FY2023 · AG

Identifying multimodal biomarkers for autologous serum tears in the treatment of chronic postoperative ocular pain

$1,557,093
Rony Roger Sayegh · Cleveland Clinic Lerner Com-Cwru · UG3 · FY2023 · NS

Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy

$1,556,553
Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2015 · CA

Integration, Dissemination and Evaluation(BRIDGE) Center for the NIH Bridge to Artificial Intelligence (BRIDGE2AI) Program

$1,556,443
Monica Cecilia Munoz-Torres · University Of Colorado Denver · U54 · FY2025 · HG

Consortium for Translational Research in Marfan Syndrome

$1,556,216
Francesco B Ramirez · Icahn School Of Medicine At Mount Sinai · P01 · FY2012 · AR

Develop, Optimize and Commercialize UltraMarathonRT: A new enzyme for unbiased transcriptomic and epitranscriptomic characterization of RNAs regardless of length or composition.

$1,555,946
Li-Tao Guo · Rnaconnect Inc · R44 · FY2024 · GM

A comprehensive platform for novel therapy development from the microbiome

$1,555,846
Curtis Huttenhower · Broad Institute, Inc. · R24 · FY2017 · DK

Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe)

$1,555,588
Michael Benatar · University Of Miami School Of Medicine · U54 · FY2021 · NS

Human Trial of Allosteric Modulator Alpha7 Nicotinic Receptors in Schizophrenia

$1,555,289
Robert Freedman · University Of Colorado Denver · U01 · FY2012 · MH

Alopecia Areata Center for Research Translation (AACORT)

$1,554,845
Angela M Christiano · Columbia University Health Sciences · P50 · FY2021 · AR

Interdisciplinary Approach to Alzheimer Drug Discovery

$1,554,521
Samuel E Gandy · Icahn School Of Medicine At Mount Sinai · P01 · FY2007 · AG